MASTER SL Clinical Study

计划入组 150 人 · 首次发布于 2014 年 4 月 30 日

Holding, Stress, and Bonding During Therapeutic Hypothermia

计划入组 10 人 · 首次发布于 2017 年 3 月 14 日

Safety and Efficacy of the SL PLUS and the SL PLUS MIA Hip Stem

计划入组 80 人 · 首次发布于 2011 年 9 月 19 日

SL-V10 (SL VAXiGEN)

SL-651498

SL-0013

CStone Pharm (HK) Holding Limited

Hong Kong, China

BOWLIN HOLDING (HK) CO., LIMITED

Hong Kong, China

STRIDES PHARMA SCIENCE LIMITED

India

SL Bio and Horizon Space Acquisition II Corp. Announce Merger to Advance Cancer Immunotherapy and Regenerative Medicine

SL Science Advances Allogeneic Gamma Delta T Cell Platform Toward IND, Reports 2025 Financial Results Following Nasdaq Listing

Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress